Total Payments
$13,040
2024 Payments
$1,662
Companies
43
Transactions
715
Medicare Patients
4,281
Medicare Billing
$446,944
Payment Breakdown by Category
Food & Beverage$10,393 (79.7%)
Other$2,000 (15.3%)
Consulting$450.00 (3.5%)
Education$196.99 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,393 | 710 | 79.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,000 | 1 | 15.3% |
| Consulting Fee | $450.00 | 1 | 3.5% |
| Education | $196.99 | 3 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lumenis, Inc | $2,000 | 1 | $0 (2017) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,323 | 93 | $0 (2024) |
| LEO Pharma Inc. | $1,313 | 138 | $0 (2024) |
| Journey Medical Corporation | $823.69 | 44 | $0 (2024) |
| ABBVIE INC. | $708.83 | 44 | $0 (2024) |
| MAYNE PHARMA INC. | $558.18 | 37 | $0 (2022) |
| Incyte Corporation | $543.53 | 28 | $0 (2024) |
| Celltrion Healthcare Co., Ltd | $450.00 | 1 | $0 (2018) |
| MERZ NORTH AMERICA, INC. | $446.21 | 2 | $0 (2021) |
| Almirall LLC | $437.77 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,662 | 100 | Incyte Corporation ($335.53) |
| 2023 | $1,758 | 122 | AbbVie Inc. ($237.79) |
| 2022 | $1,345 | 103 | Sun Pharmaceutical Industries Inc. ($205.94) |
| 2021 | $1,479 | 102 | SUN PHARMACEUTICAL INDUSTRIES INC. ($302.16) |
| 2020 | $1,274 | 95 | Sun Pharmaceutical Industries Inc. ($296.12) |
| 2019 | $1,017 | 81 | LEO Pharma Inc. ($237.37) |
| 2018 | $1,361 | 54 | Celltrion Healthcare Co., Ltd ($450.00) |
| 2017 | $3,144 | 58 | Lumenis, Inc ($2,000) |
All Payment Transactions
715 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Immunology | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.99 | General |
| 12/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $13.43 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: DERMATOLOGY | ||||||
| 11/27/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $8.00 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.75 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.17 | General |
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.49 | General |
| Category: Immunology | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.26 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $16.65 | General |
| 11/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.38 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $5.52 | General |
| 11/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.64 | General |
| 10/17/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: DERMATOLOGY | ||||||
| 10/15/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $5.16 | General |
| 10/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.50 | General |
| Category: Dermatology | ||||||
| 10/07/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.73 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,138 | 2,653 | $257,464 | $127,999 |
| 2022 | 13 | 1,030 | 2,183 | $216,880 | $107,013 |
| 2021 | 14 | 1,076 | 2,014 | $230,354 | $117,544 |
| 2020 | 11 | 1,037 | 2,187 | $218,359 | $94,389 |
Total Patients
4,281
Total Services
9,037
Medicare Billing
$446,944
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 371 | 818 | $93,252 | $56,993 | 61.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 190 | 242 | $41,140 | $20,621 | 50.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 166 | 277 | $36,841 | $13,374 | 36.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 82 | 82 | $21,074 | $9,561 | 45.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 119 | 972 | $19,440 | $5,323 | 27.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 23 | 34 | $9,486 | $4,765 | 50.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 27 | 32 | $9,440 | $4,753 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 39 | $6,513 | $3,933 | 60.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $5,408 | $2,889 | 53.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 47 | 52 | $4,680 | $2,283 | 48.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 12 | 16 | $2,960 | $1,601 | 54.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 23 | 33 | $4,950 | $1,007 | 20.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 16 | 24 | $2,280 | $894.96 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 356 | 678 | $77,292 | $47,799 | 61.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 161 | 201 | $34,170 | $16,757 | 49.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 144 | 233 | $30,989 | $12,410 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 77 | 77 | $19,646 | $9,115 | 46.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 105 | 754 | $15,010 | $4,448 | 29.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 19 | 27 | $7,533 | $3,966 | 52.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 22 | 24 | $6,970 | $3,289 | 47.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 53 | 85 | $12,750 | $2,676 | 21.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 40 | 47 | $4,230 | $2,108 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 14 | $2,338 | $1,541 | 65.9% |
| 10060 | Simple or single drainage of skin abscess | Office | 2022 | 11 | 11 | $2,024 | $1,222 | 60.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,028 | $972.79 | 48.0% |
About Benjamin Cohen
Benjamin Cohen is a Dermatology healthcare provider based in Long Branch, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053301085.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Benjamin Cohen has received a total of $13,040 in payments from pharmaceutical and medical device companies, with $1,662 received in 2024. These payments were reported across 715 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($10,393).
As a Medicare-enrolled provider, Cohen has provided services to 4,281 Medicare beneficiaries, totaling 9,037 services with total Medicare billing of $446,944. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Long Branch, NJ
- Active Since 10/21/2005
- Last Updated 09/11/2008
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1053301085
Products in Payments
- ENSTILAR (Drug) $902.37
- ILUMYA (Biological) $789.39
- OPZELURA (Drug) $543.53
- DORYX (Drug) $485.85
- INFLECTRA (Biological) $450.00
- TargaDox (Drug) $392.80
- SKYRIZI (Biological) $371.03
- DUPIXENT (Biological) $366.31
- Seysara (Drug) $351.42
- COSENTYX (Biological) $310.58
- VTAMA (Drug) $288.96
- AMZEEQ (Drug) $272.16
- Sotyktu (Drug) $256.55
- TREMFYA (Drug) $254.12
- Ilumya (Biological) $248.62
- CLODERM (Drug) $239.97
- RINVOQ (Biological) $234.50
- ADBRY (Biological) $233.89
- Otezla (Drug) $226.74
- XEOMIN (Biological) $185.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.